Lv2
130 积分 2024-01-19 加入
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
1个月前
已完结
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
3个月前
已完结
Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study
8个月前
已完结
Assessment and treatment of osteoporosis and fractures in type 2 diabetes
8个月前
已完结
2型糖尿病患者血红蛋白水平与骨密度及骨质疏松之间的关系
8个月前
已完结
Comparative effectiveness of Denosumab vs alendronate among postmenopausal women with osteoporosis
9个月前
已完结
Increased mortality among people with anxiety disorders: total population study
1年前
已完结
Long-Term Treatment of Postmenopausal Osteoporosis
1年前
已完结
Management of Postmenopausal Osteoporosis
1年前
已完结
皖公网安备34019202002308
